Clinical Trial Update: A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031). [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing torcetrapib/atorvastatin to simvastatin in subjects with high cholesterol was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)
• Torcetrapib (torcetrapib)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer | Conditions: Hyperlipidemia, Dyslipidemia | Phase 3 | Status: TERMINATED